Discover how MUVON is transforming bladder incontinence treatment with a pioneering approach in tissue engineering in our latest interview by founded.ch . Our CEO, Deana Mohr explains how our innovative startup uses patients' own cells to regenerate pelvic muscles. This therapy has the potential to be a safer and more effective solution compared to traditional methods, offering hope to millions affected by this condition. Read the full article here to learn more about MUVON'
Invest in us to be part of a groundbreaking journey toward innovative, life-changing muscle regeneration therapies, addressing a massive global market with scalable solutions.
